Vu L. Truong - 12 May 2021 Form 4 Insider Report for Aridis Pharmaceuticals, Inc.

Role
CEO and Director, Director
Signature
/s/ Vu Truong
Issuer symbol
N/A
Transactions as of
12 May 2021
Net transactions value
$0
Form type
4
Filing time
13 May 2021, 16:15:56 UTC
Next filing
27 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDS Stock Options Award $0 +53,340 +9.8% $0.000000 599,390 12 May 2021 Common Stock 53,340 $6.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in equal installments over 12 months, beginning on May 12, 2021.